Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Onco-Nutrition and Supplements Market

Onco-Nutrition and Supplements Market Size, Share and Industry Analysis Report, Regional Outlook, Competitive Market Share & Forecast, 2024 – 2032

  • Report ID: GMI4179

Onco-Nutrition and Supplements Market Size

Onco-Nutrition and Supplements Market size is projected to expand at a notable CAGR between 2024 and 2032 attributed to the rising prevalence of cancer and the ease of availability of advanced healthcare infrastructure. As per credible sources, in the U.S. alone, 1,958,310 new cancer cases were estimated to be reported in 2023. This surging number of cancer patients is prompting the need for oncology nutrition as a proper diet provides the ability to counter the disease and endure the side effects of the treatment.

Furthermore, the emergence of several certification programs and awareness seminars across the globe to educate cancer patients and physicians on the importance of oncology nutrition will play an ideal role in the onco-nutrition and supplements market expansion. The Cancer Nutrition Institute, for example, offers evidence-based educational certification and training programs in metabolic, contemporary, creative, outcomes-based, and integrative oncology nutrition treatment.

With the unprecedented strain on healthcare systems, the COVID-19 outbreak increased the importance of nutritional oncology for maintaining a proper diet and strengthening the patient immune system to aid the battle against the novel infection. The higher inclination to appropriate nutrition among cancer patients is further providing potential progression opportunities for the introduction of new on-nutrition products and supplements in the post-pandemic era.

Onco-Nutrition and Supplements Market Trends

Ongoing medical advancements are improving cancer treatment outcomes, increasing the emphasis on enhancing the quality of life for survivors, projecting multiple expansion opportunities for industry expansion. Onco-nutrition and supplements play a crucial role in addressing post-treatment challenges, including nutritional deficiencies and side effects. Moreover, the rise in survivorship-focused R&D results in innovative onco-nutritional products are helping meet the unique dietary needs of cancer survivors.

For instance, in May 2023, the American College of Surgeons' Commission on Cancer (CoC) and Cancer Research Program established a new Survivorship Services Survey for its CoC-accredited hospitals and cancer facilities. However, the market may face constraints, such as limited reimbursement policies, regulatory challenges, and varying patient adherence, subsequently hindering the widespread product adoption in certain regions.

Onco-Nutrition and Supplements Market Analysis

By cancer type, the market share from the head and neck cancer segment is expected to grow significantly between 2024 and 2032 due to the increasing relevance of nutrition among persons affected by this condition. It is estimated that nearly 30% to 50% of head and neck cancer patients are malnourished before the beginning of therapy. The growing need for satisfying nutritional needs among this patient pool to minimize catabolism is likely to drive the product demand.

Based on end-use, the onco-nutrition and supplements industry size from hospitals is anticipated to depict commendable demand through 2032. This is mainly powered by numerous services offered by hospitals, including medical nutrition treatment, as well as before and post-operative patient counseling. Moreover, the rising cancer incidence, the transition from parenteral to enteral nutrition, and improved clinical research quality on nutritional therapies.


Regionally, the North America onco-nutrition and supplements market is set to exhibit robust gains from 2024-2032 driven by the rising public awareness regarding the early-stage diagnosis and treatment of cancer. According to the American Cancer Society, the Get Screened project has significantly increased cancer screening rates in 2023. With considerable R&D efforts led into cancer treatment, the demand for subsequent onco-nutrition and supplements is likely to upsurge, further augmenting the regional industry outlook.

Onco-Nutrition and Supplements Market Share

The competitive landscape of the onco-nutrition and supplements industry is inclusive of prominent companies, such as:

  • Abbott
  • Danone
  • B. Braun Melsungen AG
  • Hormel Foods
  • Global Health Products
  • Nestle S.A.

Leading onco-nutrition and supplement companies are strategically consolidating their revenue share by focusing on research, product developments, and partnerships. By emphasizing innovations and understanding the specific nutritional needs of cancer patients, these market contenders are aiming to establish a stronger presence in the evolving healthcare segment. To illustrate, Nestle S.A. emerged as a key market player, providing specialized nutritional products to support cancer patients, enhance recovery, and improve overall well-being.

Onco-Nutrition and Supplements Industry News

  • In January 2024, Danone and Resilience collaborated to develop the first-ever nutrition and oncology module, which is now incorporated into the latter’s digital oncology platform.

What Information does this report contain?

Historical data coverage: 2018 to 2023; Growth Projections: 2024 to 2032.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.
Authors: Mariam Faizullabhoy

Buy Now

Access to only 1 person; cannot be shared; cannot be printed

Access for 2 to 5 users only within same department of one company

Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Buy Now

Access to only 1 person; cannot be shared; cannot be printed

Access for 2 to 5 users only within same department of one company

Access to a company wide audience; includes subsidiary companies or other companies within a group of companies